Business Wire
17 Feb 2026, 21:05 UTC · 31w ago
Verdict
Headline takes no side. We score MED −0.80 across three claims — strongly bearish.
−0.80strongly bearish
More negative than 86% of ticker scores this week
What the story claims
3 claims · scored −1 bearish … +1 bullish
Medifast reported a net loss of $18.1 million (or $1.65 per diluted share) for the fourth quarter ended December 31, 2025.
So whatA significant net loss and negative EPS indicate poor profitability and operational struggles, which typically trigger a sell-off in equity.
More negative than 99% of claims this week
Fourth quarter 2025 revenue was $75.1 million.
Continue reading
5 related stories
Scored by the NIS engine · methodology.
More negative than 71% of claims this week
The company had 16,100 independent active earning coaches with revenue per active earning coach of $4,664.
So whatThese are baseline operational metrics that provide context but do not signal a major shift in valuation without historical comparison.
Near neutral — 99% of claims this week are stronger
Which stocks this story touches
More negative than 86% of ticker scores this week
The company reported a net loss of $18.1 million for the fourth quarter.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
+11.1%
Price is moving against the score
$12.00 vs $10.80 close before publication (Feb 17) · not market-adjusted
MED chart →
